Dis-Chem Pharmacies Limited

JSE:DCP Stock Report

Market Cap: R26.3b

Dis-Chem Pharmacies Past Earnings Performance

Past criteria checks 3/6

Dis-Chem Pharmacies has been growing earnings at an average annual rate of 10.6%, while the Consumer Retailing industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 10.6% per year. Dis-Chem Pharmacies's return on equity is 22%, and it has net margins of 2.6%.

Key information

10.6%

Earnings growth rate

10.6%

EPS growth rate

Consumer Retailing Industry Growth8.2%
Revenue growth rate10.6%
Return on equity22.0%
Net Margin2.6%
Next Earnings Update31 May 2024

Recent past performance updates

Recent updates

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25
The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23
Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13
I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09
Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Revenue & Expenses Breakdown
Beta

How Dis-Chem Pharmacies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

JSE:DCP Revenue, expenses and earnings (ZAR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 2334,1918991,0060
31 May 2333,4279491,0060
28 Feb 2332,6641,0001,0060
30 Nov 2232,2311,0209150
31 Aug 2231,7981,0408240
31 May 2231,1029468240
28 Feb 2230,4078538240
30 Nov 2129,4078152,8940
31 Aug 2128,4077764,9640
31 May 2127,3437224,9640
28 Feb 2126,2786694,9640
30 Nov 2025,6116554,5060
31 Aug 2024,9446414,0490
31 May 2024,4646204,0490
29 Feb 2023,9845984,0490
30 Nov 1923,3945733,7480
31 Aug 1922,8035493,4480
31 May 1922,1116343,4480
28 Feb 1921,4207193,4480
30 Nov 1820,8987183,2390
31 Aug 1820,3767183,0310
31 May 1819,9287013,0310
28 Feb 1819,4806843,0310
30 Nov 1718,9197152,8310
31 Aug 1718,3597462,6310
31 May 1717,8146792,6310
28 Feb 1717,2686122,6310
30 Nov 1616,7945481,5770
31 Aug 1616,3204845240
31 May 1615,6914985240
29 Feb 1615,0615135240
28 Feb 1512,9114342,3210
28 Feb 1410,3214091,8340

Quality Earnings: DCP has high quality earnings.

Growing Profit Margin: DCP's current net profit margins (2.6%) are lower than last year (3.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DCP's earnings have grown by 10.6% per year over the past 5 years.

Accelerating Growth: DCP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DCP had negative earnings growth (-13.6%) over the past year, making it difficult to compare to the Consumer Retailing industry average (-3.8%).


Return on Equity

High ROE: DCP's Return on Equity (22%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.